Drawing for NEUTRAPLEX

USPTO serial 75528461

NEUTRAPLEX

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
—
Law office
FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with NEUTRAPLEX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

HAROLD J MILSTEIN

HAROLD J MILSTEIN WILSON SONSINI GOODRICH & ROSATI PC650 PAGE MILL RDPALO ALTO, CA 94304UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001chemicals for use in the manufacture of pharmaceutical productsACTIVE—
005pharmaceutical preparations, namely, drug delivery systems; nucleic acids delivery systems, drug carriers, nucleic acids carriers, pharmaceutical excipients, drug adjuvants, drug activators and drug penetration enhancers; pharmaceutical preparations for use in the treatment of neurological diseases, pain, cancer, immunological diseases, allergies, otorhinolaryngological diseases, pneumological, and ophtalmological diseases; and pharmaceutical preparations for use in gene therapy and diagnosticsACTIVE—
042research in the cosmetological area, research in the pharmaceutical area, research in the area of medical, health and beauty care; scientific and industrial research, biological research, consulting activities in the pharmaceutical area, chemical analysis; chemical research, chemical services, consulting activities the area of cosmetology, research in the area of physics, scientific and technical support in the area of analytical projects and drug and other compound formulation for the pharmaceutical, cosmetics, food and chemical industries; research and development in the area of formulating drugs and other compounds; granting of licenses with respect to patents, trademarks and copyrightACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (ABN6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Aug 14, 2003ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Nov 19, 2002NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Aug 27, 2002PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 7, 2002NPUBNOTICE OF PUBLICATION—
Jun 13, 2002CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 10, 2002PETGPETITION TO REVIVE-GRANTED—
Dec 10, 2001PETRPETITION TO REVIVE-RECEIVED—
Oct 26, 2001ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Feb 14, 2001CNSIINQUIRY AS TO SUSPENSION MAILED—
Jul 3, 2000CNSLLETTER OF SUSPENSION MAILED—
Jun 29, 2000CNEAEXAMINER'S AMENDMENT MAILED—
May 19, 2000CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 19, 1999CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Oct 22, 1999CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 23, 1999CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 30, 1999DOCKASSIGNED TO EXAMINER—
Mar 24, 1999DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance